Lingyun Sun

3.0k total citations · 1 hit paper
96 papers, 1.8k citations indexed

About

Lingyun Sun is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Lingyun Sun has authored 96 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Rheumatology, 38 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Lingyun Sun's work include Systemic Lupus Erythematosus Research (26 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Salivary Gland Disorders and Functions (11 papers). Lingyun Sun is often cited by papers focused on Systemic Lupus Erythematosus Research (26 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Salivary Gland Disorders and Functions (11 papers). Lingyun Sun collaborates with scholars based in China, United States and Macao. Lingyun Sun's co-authors include Yuanjin Zhao, Xiaoxuan Zhang, Jingjing Gan, Wenjuan Ma, Weilin Liu, Lu Fan, Yuxiao Liu, Guopu Chen, Xuebing Feng and Genhong Yao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and PLoS ONE.

In The Last Decade

Lingyun Sun

92 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polydopamine Decorated Microneedles with Fe‐MSC‐Derived Nanovesicles Encapsulation for Wound Healing

2022 284 citations Wenjuan Ma, Jingjing Gan et al. Advanced Science profile →

Peers

Countries citing papers authored by Lingyun Sun

Since Specialization

Citations

This map shows the geographic impact of Lingyun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Sun more than expected).

Fields of papers citing papers by Lingyun Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Sun. The network helps show where Lingyun Sun may publish in the future.

Co-authorship network of co-authors of Lingyun Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Sun. A scholar is included among the top collaborators of Lingyun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Sun. Lingyun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MiR-125a-5p in MSC-derived small extracellular vesicles alleviates Müller cells injury in diabetic retinopathy by modulating mitophagy via PTP1B pathway 2025 ·Cell Death Discovery ·(unknown), (unknown), (unknown), Chang He, (unknown), (unknown), Hanqin Lei, Lingyun Sun, Genhong Yao, (unknown)	3
2	Dexamethasone loaded DNA scavenger nanogel for systemic lupus erythematosus treatment 2024 ·Bioactive Materials ·Haofang Zhu, Danqing Huang, Min Nie, Yuanjin Zhao, Lingyun Sun	14
3	Risk factors for initial and recurrent severe infections in first hospitalized patients with systemic lupus erythematosus: A retrospective study of a Chinese cohort 2024 ·International Journal of Rheumatic Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), Xuefeng Xu, Genhong Yao, (unknown), Dandan Wang, Huayong Zhang, Xuebing Feng, Ziyi Jin, Lingyun Sun	2
4	Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial Spondyloarthritis 2024 ·Rheumatology and Therapy ·(unknown), (unknown), Dongzhou Liu, Jingyang Li, Huaxiang Wu, Lingyun Sun, Lie Dai, Chunyu Tan, Zhijun Li, (unknown), Xiaomei Li, Yan Yan, (unknown), (unknown), Hejian Zou	1
5	Metabolic alterations in vitamin D deficient systemic lupus erythematosus patients 2024 ·Scientific Reports ·Yunxia Yan, Fangyuan Yu, Qi Li, Xuebing Feng, Linyu Geng, Lingyun Sun	2
6	ECM‐Inspired Hydrogels with ADSCs Encapsulation for Rheumatoid Arthritis Treatment 2023 ·Advanced Science ·Haofang Zhu, Xiangyi Wu, Rui Liu, Yuanjin Zhao, Lingyun Sun	37
7	IFIH1 was predicted as a key biomarker in primary Sjögren's syndrome based on transcriptome analysis and experimental verification in patients and mice 2023 ·International Journal of Rheumatic Diseases ·Dan Wu, Liang Chen, Dandan Wang, Yuchun Wang, Genhong Yao, Lingyun Sun	2
8	A novel mechanism for macrophage pyroptosis in rheumatoid arthritis induced by Pol β deficiency 2022 ·Cell Death and Disease ·(unknown), (unknown), Ting Wu, Ge Chen, (unknown), Lianfeng Zhao, Lingfeng He, Zhigang Hu, Lingyun Sun, Feiyan Pan, Zhimin Yin, Zhigang Guo	31
9	Biologics‐Loaded Photothermally Dissolvable Hyaluronic Acid Microneedle Patch for Psoriasis Treatment 2022 ·Advanced Functional Materials ·Dan Wu, Xin Shou, Yunru Yu, Xiaocheng Wang, Guopu Chen, Yuanjin Zhao, Lingyun Sun	65
10	Mesenchymal Stem Cell Exosomes Encapsulated Oral Microcapsules for Acute Colitis Treatment 2022 ·Advanced Healthcare Materials ·Jingjing Gan, Lingyu Sun, Guopu Chen, Wenjuan Ma, Yuanjin Zhao, Lingyun Sun	43
11	Bio‐Inspired Imprinting Materials for Biomedical Applications 2022 ·Advanced Science ·Hanxu Chen, Jiahui Guo, Yu Wang, Weiliang Dong, Yuanjin Zhao, Lingyun Sun	47
12	Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis 2022 ·Clinical Rheumatology ·(unknown), (unknown), Ju Li, Zhongyuan Zhang, Xin Wen, Hongwei Chen, Lingyun Sun	4
13	Multiplexed CRISPR/Cas9 quantifications based on bioinspired photonic barcodes 2021 ·Nano Today ·Dagan Zhang, Lijun Cai, Xiaowei Wei, Yuetong Wang, Luoran Shang, Lingyun Sun, Yuanjin Zhao	32
14	Kaempferol alleviates LD-mitochondrial damage by promoting autophagy: Implications in Parkinson's disease 2021 ·Redox Biology ·Xiaojuan Han, Shengnan Zhao, (unknown), Tianshu Xu, Qi‐Jun Fang, Gang Hu, Lingyun Sun	80
15	Prognostic Indicators of Hospitalized Patients with Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study in China 2011 ·The Journal of Rheumatology ·Xuebing Feng, (unknown), Wenyou Pan, (unknown), Min Wu, Miaojia Zhang, Juan Tao, Yu Zhang, (unknown), (unknown), Zhiwei Chen, Xiang Ding, Xian Qian, Zhanyun Da, Meimei Wang, Lingyun Sun	43
16	Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis 2011 ·Annals of the Rheumatic Diseases ·(unknown), Hao Zhang, Mengshu Cao, Yaqiong Tang, (unknown), Xuebing Feng, (unknown), Bingzhu Hua, B. Liu, Lingyun Sun	63
17	Artesunate relieves lupus nephritis by inhibiting the expression of ICAM-1 2010 ·Lingyun Sun	4
18	Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese 2010 ·Annals of the Rheumatic Diseases ·(unknown), Yi Liu, Patrick Danoy, Xinyu Wu, Gethin Thomas, Lindi Jiang, Lingyun Sun, (unknown), Jing Han, Hui Han, Peter M. Visscher, Matthew A. Brown, Huji Xu	98
19	Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial 2008 ·Chinese Medical Journal ·Liangjing Lu, Jialin Teng, Chunde Bao, (unknown), Lingyun Sun, (unknown), (unknown), Huaxiang Wu	30
20	Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial 2003 ·eCite Digital Repository (University of Tasmania) ·Chunde Bao, Shun‐le Chen, Yueying Gu, (unknown), Liqing Ni, Qiang Yu, Jianhua Xu, (unknown), Jialing Liu, Lingyun Sun, (unknown), (unknown), (unknown), Changhai Ding	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact